BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12957258)

  • 1. Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma: a 10-year update of a phase II study.
    Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J; Stojanovic M
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):465-71. PubMed ID: 12957258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A
    Radiother Oncol; 1998 Oct; 49(1):49-54. PubMed ID: 9886697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
    Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
    Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T; Nichols D; Ivnik R; Hellman R; Curran W; Abrams R
    J Clin Oncol; 2002 May; 20(9):2267-76. PubMed ID: 11980997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN; Zhang P; Yung WKA; Chen Y; Movsas B; Urtasun RC; Jones CU; Choi KN; Michalski JM; Fischbach AJ; Markoe AM; Schultz CJ; Penas-Prado M; Garg MK; Hartford AC; Kim HE; Won M; Curran WJ
    J Neurooncol; 2018 Mar; 137(1):39-47. PubMed ID: 29404979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
    Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
    Daniels TB; Brown PD; Felten SJ; Wu W; Buckner JC; Arusell RM; Curran WJ; Abrams RA; Schiff D; Shaw EG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):218-24. PubMed ID: 21549518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Stojanovic M; Milicic B; Nikolic N; Dagovic A; Aleksandrovic J
    J Neurooncol; 2001 Jan; 51(2):133-41. PubMed ID: 11386410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperfractionated radiotherapy and adjuvant chemotherapy in patients with malignant gliomas].
    Jeremić V; Grujicić D; Samarcić M; Antunović V; Joksimović M; Milicić B; Rasulić L; Nikolić N
    Srp Arh Celok Lek; 1997; 125(11-12):333-9. PubMed ID: 9480566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
    Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective clinical trials of intracranial low-grade glioma in adults and children.
    Shaw EG; Wisoff JH
    Neuro Oncol; 2003 Jul; 5(3):153-60. PubMed ID: 12816721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy for incompletely resected supratentorial low-grade glioma in adults.
    Jeremic B; Bamberg M
    J Neurooncol; 2001 Nov; 55(2):101-12. PubMed ID: 11817700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
    Corn BW; Yousem DM; Scott CB; Rotman M; Asbell SO; Nelson DF; Martin L; Curran WJ
    Cancer; 1994 Nov; 74(10):2828-35. PubMed ID: 7954244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas.
    Fisher BJ; Leighton CC; Vujovic O; Macdonald DR; Stitt L
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):704-10. PubMed ID: 11597812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy in supratentorial gliomas. A study of 821 cases.
    Heesters M; Molenaar W; Go GK
    Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.